Covance adding mass spec for biosimilars
Covance is adding mass spectrometry and other capabilities to meet growing demand for biosimilar comparability services.
View ArticleParexel adds imaging tech for early phase CNS research
Parexel has added functional magnetic resonance imaging technology (fMRI) to its early phase units to advance CNS research.
View ArticleForming CRO spin-outs can help big pharma; research
Spinning-out assets to form a CRO can help large biopharm commercialise knowledge and focus on core activities, research found.
View ArticleTake Solutions inks Mene deal for emerging market services
Take Solutions has partnered with Turkish CRO Mene Research to offer drug safety services in emerging markets.
View ArticleHong Kong the latest regulator to recall drugs from Ben Venue
The Hong Kong DH has become the latest regulator to take action against products manufactured by Ben Venue Laboratories.
View ArticleBiotechs fear being overlooked by the big CROs; Covance
Fear of getting “lost in the shuffle” makes some biotechs nervous about outsourcing to big CROs, a Covance VP said.
View ArticleIndian trial compensation guidelines open to comment
India is seeking comments on draft guidelines that detail sponsors’ clinical trial injury compensation responsibilities.
View ArticleRussian rules on local trials blow for drug sector and boon for unethical CROs
The requirement for local clinical trials has been a ‘serious blow’ to Russia’s drug approval system and an opportunity for unethical CROs according to the Moscow-based Association of Clinical Trial...
View ArticleUBC looking to ‘buy or build’ to serve strategic partnerships
UBC expects strategic outsourcing of outcomes and personalised medicine research to accelerate as biopharm cut fixed costs.
View ArticleAnalysts back CMO Arch’s IPO on CRAMS biz potential
An expanding CRAMS business and bulk drug strength makes Indian CMO Arch Pharmalabs’ IPO a solid investment, analysts report.
View ArticlePeople on the move: outsourcing jobs
Outsourcing Pharma presents its latest round-up of the movers and shakers within the pharmaceutical industry, including news from Icon, Cenduit and BIA.
View ArticleGVK inks drug discovery deal
GVK Biosciences is working with the Moulder Center on target validation and lead identification of small molecules.
View ArticleAstraZeneca inks multi-year Cognizant biostatistics deal
AstraZeneca is outsourcing biostatistics and medical reporting work to Cognizant in a multi-year agreement.
View ArticleIndianapolis CROs partner to accelerate preclinical testing
AIT Bioscience and PreClinOmics have partnered to give clients absorption and distribution data earlier in development.
View ArticleLonza to supply Elan with API for trials of candidate Alzheimer’s disease drug
Chemicals supplier Lonza will manufacture the API for a candidate Alzheimer’s disease drug being developed by Elan in an agreement announced yesterday.
View ArticleStrategic deal visibility creating opportunities for small CROs
Online 24/7 news has accentuated big CROs’ ties to large pharma and created opportunities for smaller vendors, a CEO said.
View ArticleRise of Asian biopharm creates investment targets for Quintiles
Quintiles expects to make more investments in Asia-Pacific partnerships as the local biopharm sector grows.
View ArticlePPD shareholders support private equity takeover
PPD shareholders have cleared the way for private equity firms to buy the CRO by voting in favour of the takeover.
View ArticleUS firm offering modular plant leases as alternative to CMOs
Biologics Modular is leasing its mobile production facilities to help clients make FDA regulated drugs without fixed plants.
View ArticleUK government make health data available in bid to boost R&D sector
Pharma companies and contract research organisations will soon be able to view important UK health data.
View Article
